12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

  • GT Biopharma GTBP shares rose 173.5% to $8.53 during Monday's regular session. The market value of their outstanding shares is at $11.7 million. As per the press release, Q1 earnings came out 3 days ago.
  • NovaBay Pharmaceuticals NBY shares rose 78.07% to $0.21. The company's market cap stands at $7.9 million.
  • NKGen Biotech NKGN stock moved upwards by 48.66% to $1.67. The market value of their outstanding shares is at $37.4 million.
  • Scorpius Holdings SCPX shares rose 36.98% to $0.14. The market value of their outstanding shares is at $5.1 million.
  • Scilex Holding SCLX stock moved upwards by 32.22% to $1.19. The market value of their outstanding shares is at $144.1 million.
  • Hims & Hers Health HIMS shares moved upwards by 31.88% to $19.21. The market value of their outstanding shares is at $4.1 billion.

Losers

  • Virios Therapeutics VIRI shares decreased by 43.1% to $0.2 during Monday's regular session. The company's market cap stands at $3.8 million.
  • Jaguar Health JAGX shares declined by 37.22% to $0.16. The market value of their outstanding shares is at $47.6 million. As per the press release, Q1 earnings came out 4 days ago.
  • DermTech DMTK stock declined by 33.88% to $0.33. The company's market cap stands at $11.5 million. As per the press release, Q1 earnings came out 4 days ago.
  • Akanda AKAN stock decreased by 29.32% to $0.12. The market value of their outstanding shares is at $3.9 million.
  • Aesthetic Medical Intl AIH shares fell 25.86% to $0.37. The company's market cap stands at $17.6 million.
  • Lucy Scientific Discovery LSDI shares decreased by 20.55% to $1.16. The company's market cap stands at $2.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!